Enigma Diagnostics

Enigma Diagnostics, founded in 2004, is a developer of fully automated molecular testing devices for clinics. The PCR MiniLab platform enables clinicians to access rapid, comprehensive, and actionable laboratory-quality molecular diagnostic results 24/7, allowing for the simultaneous in vitro diagnostic testing of a range of targets, thereby reducing wait times for test results to about an hour. Extensive literature demonstrates that rapid and accurate diagnosis, along with targeted treatment, can improve clinical outcomes while reducing costs and supporting effective antimicrobial stewardship. The MiniLab is designed to support clinical sample collection workflows by minimizing pipetting steps and allows laboratories to "push" their services to decentralized labs. Built-in quality control features enable laboratories to oversee the use of the platform, while data integration facilitates result transmission.